| Chen, Kai |
TOP-CABG, NCT05380063: Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting |
|
|
| Recruiting | 4 | 2300 | RoW | De-escalated Dual Antiplatelet Therapy, De-escalation, Dual Antiplatelet Therapy | China National Center for Cardiovascular Diseases | Coronary Artery Disease, Coronary Artery Bypass Grafting, Dual Antiplatelet Therapy, Bleeding, Myocardial Infarction, Myocardial Ischemia, Angina Pectoris | 12/24 | 12/25 | | |
OFFER, NCT04536558: Olanzapine Plus Fosaprepitant Standard Antiemetic Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving High Emetic Risk Multi-day Chemotherapy: a Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study |
|
|
| Not yet recruiting | 3 | 352 | RoW | olanzapine plus fosaprepitant-based triple regimen, placebo plus fosaprepitant-based triple regimen | Sun Yat-sen University, Jiangsu Hansoh Pharmaceutical Co., Ltd. | Solid Tumor Patients Receiving High Emetic Risk Multi-day Chemotherapy | 02/21 | 03/21 | | |
NCT04714190: A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression |
|
|
| Recruiting | 3 | 351 | RoW | RC48-ADC, Recombinant Humanized anti-HER2 Monoclonal Antibody-MMAE Conjugate For Injection, Paclitaxel injection, Taxol, Irinotecan Hydrochloride Injection, CAMPTO, Apatinib Mesylate Tablets, Aitan | RemeGen Co., Ltd. | Gastric Cancer, HER2 Overexpressing Gastric Carcinoma | 12/24 | 06/25 | | |
| Recruiting | 3 | 315 | RoW | TQB2450, Anlotinib, TQB2450(blank), Anlotinib(blank) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Stage III Non-small-cell Lung Cancer | 12/22 | 03/25 | | |
| Recruiting | 3 | 400 | Europe, Canada, Japan, US, RoW | tucatinib, TUKYSA, ONT-380, ARRY-380, PF-07265792, trastuzumab, Herceptin, bevacizumab, Avastin, cetuximab, Erbitux, oxaliplatin, leucovorin, levoleucovorin, fluorouracil | Seagen Inc., Merck Sharp & Dohme LLC | Colorectal Neoplasms | 08/25 | 04/28 | | |
MA-BC-II-018, NCT04872985: Pyrotinib in Combination with Neoadjuvant Chemotherapy in HR+/HER2-, HER4 High Expression Breast Cancer Patients: a Phase II Trial |
|
|
| Recruiting | 2 | 140 | RoW | Pyrotinib, Epirubicin, E, Doxorubicin Hydrochloride Liposome Injection, A, Cyclophosphamide, C, Docetaxel, T, Nab paclitaxel, Placebo | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Jiangsu HengRui Medicine Co., Ltd. | Breast Cancer, Hormone-receptor Positive Breast Cancer | 12/25 | 12/28 | | |
NCT05729399: Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors |
|
|
| Recruiting | 1/2 | 42 | RoW | GT201 | Grit Biotechnology | Solid Tumor | 05/25 | 05/25 | | |
NCT04003558: Deep Learning Algorithms for Prediction of Lymph Node Metastasis and Prognosis in Breast Cancer MRI Radiomics (RBC-01) |
|
|
| Recruiting | N/A | 1500 | RoW | No interventions | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Sun Yat-sen University, Tungwah Hospital of Sun Yat-Sen University, Shunde Hospital of Southern Medical University, Zhongshan Ophthalmic Center, Sun Yat-sen University | Breast Neoplasm Female, Early-stage Breast Cancer, Radiomics, Axillary Lymph Node, Survival, Prosthesis | 05/20 | 01/25 | | |
RBC-02, NCT04004559: MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognosis |
|
|
| Recruiting | N/A | 600 | RoW | No interventions | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Sun Yat-sen University, Tungwah Hospital of Sun Yat-Sen University | Invasive Breast Cancer, Neoadjuvant Chemotherapy, Radiomics, Axillary Lymph Node, Prognosis | 10/20 | 05/25 | | |
NCT04004494: 3D Reconstruction in Video-assisted Thoracoscopic Surgery (VATS) Segmentectomy |
|
|
| Completed | N/A | 191 | RoW | 3D reconstruction | Ruijin Hospital, Union hospital of Fujian Medical University, Guangdong Provincial People's Hospital | Segmentectomy | 10/23 | 12/23 | | |
PREPOSE, NCT03010033: Effect of Pulmonary Rehabilitation on Perioperative Outcomes in Smoker Patients With Lung Cancer |
|
|
| Recruiting | N/A | 200 | RoW | pulmonary rehabilitation | Ruijin Hospital | Pulmonary Neoplasm | 09/22 | 12/22 | | |
| Recruiting | N/A | 30 | US | beta blocker discontinuation | UConn Health | Heart Failure With Preserved Ejection Fraction | 11/22 | 11/22 | | |
NCT06425874: The Impact of Socioeconomic Determinants on the Patient Reported Outcomes in Young Breast Cancer Patients After Breast Surgery |
|
|
| Recruiting | N/A | 1000 | RoW | Breast-conserving surgery, Mastectomy, Mastectomy with reconstruction | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Breast Cancer, Surgery, Quality of Life | 12/35 | 12/35 | | |
NCT06510127: An AI Model Predicts the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer: a Multicenter, Bidirectional Cohort Study |
|
|
| Enrolling by invitation | N/A | 840 | RoW | | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, First Affiliated Hospital of Jinan University | Breast Cancer | 06/25 | 01/26 | | |
NCT06667609: Validity and Reliability of the Mastitis Symptom Severity Assessment Methods (M-Score and BISSI) in Non-Lactational Mastitis |
|
|
| Recruiting | N/A | 300 | RoW | Any treatments regimen, Surgery, Corticosteroids, Ductal lavage, Anti-TB treatments, Observations, Aspirations, Immuno-suppression medications | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Granulomatous Mastitis, Mastitis Chronic | 06/27 | 06/27 | | |
NCT06665399: Observation Alone for Mild Non-Lactational Mastitis |
|
|
| Recruiting | N/A | 57 | RoW | Observation | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Granulomatous Mastitis, Mastitis Chronic | 12/27 | 12/27 | | |
NCT05638269: A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China |
|
|
| Recruiting | N/A | 12000 | RoW | no intervention | Zhujiang Hospital, National Natural Science Foundation of China | Essential Hypertension, Liver Cancer, Nasopharyngeal Cancer, Pancreatic Cancer, Lung Cancer, Chronic Kidney Diseases, Acute Coronary Syndrome, Epilepsy, Gastric Cancer, Primary Aldosteronism, Subclinical hypothyroïdism | 12/24 | 12/25 | | |
